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INTRODUCTION 
IBS is common and clinically heterogeneous gastrointestinal disorder that can be divided 
into four subtypes: IBS with constipation (IBS-C), IBS with diarrhea (IBS-D), IBS with mixed 
bowel habits, and unclassified IBS. IBS decreases quality of life1 and imposes a substantial 
economic burden on the healthcare system.2 In order to develop efficient approaches to address 
the individual needs of IBS patients while minimizing healthcare resource overutilization, it is 
important to identify the factors that drive patients to seek care, clarify the burden associated 
with distinct IBS subtypes, and to be aware of the resources from which IBS patients seek 
health-related information. We aimed to compare healthcare and information seeking between 
individuals with IBS-C and IBS-D.  
METHODS 
The study cohort 
Adults ages 18-100 years were recruited from a national sample to participate in an online 
consumer survey study between September 14, 2015 and October 21, 2015 to assess healthcare 
and information seeking. Details of the study design are described elsewhere.3  
Statistical analysis 
Associations of healthcare and information seeking with IBS subtype were examined using 
multivariate logistic regression, negative binomial regression, and the proportional odds model 
where appropriate adjusting for relevant covariates (age, sex, race/ethnicity, marital status, 
education level, employment status, and IBS diagnosed by a doctor).  
RESULTS 
Healthcare seeking in IBS-C and IBS-D: Among 3,254 participants, 82% (N=2674) reported 
speaking to at least one healthcare professional about their symptoms. Women with IBS-D were 
associated with a decreased odds ratio (OR, 95% C.I.) of seeking care from an 
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obstetrician/gynecologist or a pharmacist than women with IBS-C. Among those who saw at 
least one healthcare professional (N=2674), there were no significant differences in the number 
of healthcare professionals ever spoken to. However, IBS-D was associated with a decreased 
number (8% less) of healthcare professionals spoken to in the past twelve months compared to 
IBS-C. Comparisons of reasons for which participants waited to seek care revealed that IBS-C 
participants (16.3%) reported that other health conditions took priority more frequently than IBS-
D participants (8.0%). Results are summarized in the Table.  
Resources and information seeking in IBS-C and IBS-D: Only 15% of respondents had not 
discussed their gastrointestinal symptoms with anyone. IBS-D participants more frequently 
discussed their symptoms with others than IBS-C participants. Among those (N=2757) who had 
spoken to someone other than a doctor, 59% (N=1625) reported receiving advice for their 
symptoms and 90% (N=1465) of those receiving advice reported following it. Univariate 
analyses revealed significant differences in the proportion of individuals with IBS-C vs. IBS-D 
who received (63.1% IBS-C, 56.8% IBS-D, p<0.001) and followed advice (91.6% IBS-C, 88.6% 
IBS-D, p=0.048).  Overall, 67.7% reported seeking information on IBS from their doctor, 64.5% 
from online sources, and 45.5% from Google or other search engines. IBS-C participants more 
frequently utilized social media networks, television, pharmaceutical or healthcare companies, 
and product websites than IBS-D participants (Table) 
DISCUSSION 
In this large nationwide survey study, we found that IBS-C participants were more likely 
to discuss symptoms with an obstetrician/gynecologist than IBS-D participants. This association 
may be due to previously described relationships between chronic pelvic pain,4 dyssynergic 
defecation,5 or pelvic floor related symptoms6 and constipation. IBS-C participants were less 
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likely to discuss symptoms with other individuals within their social networks than those with 
IBS-D, suggesting that IBS-C may often be a private and isolating experience. IBS-C 
participants also reported speaking to a higher number of healthcare professionals in the past 12 
months and more frequently reported that other health conditions took priority.  Although the 
reasons for these observations are unclear, it is possible that IBS-C patients may exhibit a higher 
frequency of care-seeking within defined time periods as previously reported by others7 and that 
symptoms of constipation could be a surrogate for poorer health as suggested in another 
population-based study8  
Study limitations include the possibility of recall and responder bias and the inability to 
confirm diagnoses by review of the medical records or by physician assessments. This study was 
conducted within the U.S. and participants were recruited from all 50 states in order to ensure 
individuals from all regions had an equal chance of being invited to participate. However, the 
study sample was not nationally representative and results may not be generalizable to other 
regions of the world.  
In summary, study findings suggest that patient attitudes towards healthcare and 
knowledge gathering differ by IBS subtype. Further studies are required to verify these potential 
associations as recognizing these differences will be important in addressing the unique needs of 
IBS patients and reducing the associated burden of illness. 
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Table: Summary of Effects of Irritable Bowel Syndrome (IBS) Subtype on Healthcare and 
Information Seeking Behaviors Based on Multivariate Analyses 
*IBS-D vs. IBS-C
(95% CI) p-value
Types of healthcare professionals consulted 
 A primary care physician 1.02 (0.85, 1.22) 0.82 
 A gastroenterologist 0.88 (0.75, 1.04) 0.13 
 Obstetrician/Gynecologist (women only) 0.71 (0.59, 0.86) <0.001 
 Nurse/Nurse practitioner 0.97 (0.83, 1.13) 0.66 
 Physician’s assistant 0.99 (0.84, 1.17) 0.9 
 Pharmacist 0.81 (0.67, 1.00) 0.045 
 Proctologist/colorectal Surgeon 1.01 (0.79, 1.30) 0.92 
 Other 0.89 (0.62, 1.27) 0.51 
Number of healthcare professionals (HCP) ever spoken to 1.07 (0.99, 1.15) 0.1 
Number of HCP spoken to in the past 12 months 0.92 (0.86, 0.98) 0.009 
Duration of symptoms before seeing a doctor 0.91 (0.80, 1.05) 0.2 
Reason why patient waited to talk to provider 
Symptoms weren’t important enough 1.04 (0.81, 1.32) 0.78 
Symptoms were severe enough 1.16 (0.98, 1.38) 0.093 
Other health conditions that take priority 0.45 (0.35, 0.57) <0.001 
Felt I should deal with it on my own 0.90 (0.68, 1.20) 0.48 
Didn’t think there was anything they could do 1.15 (0.93, 1.43) 0.2 
Too embarrassed 0.93 (0.72, 1.20) 0.59 
Have learned to deal with it on my own 1.25 (0.94, 1.66) 0.13 
Other 1.51 (1.12, 2.04) 0.007 
Individuals with whom participants discussed symptoms 
Spouse/partner 1.06 (0.88, 1.28) 0.55 
Significant other/person you are dating 1.22 (0.98, 1.53) 0.077 
Kids 1.40 (1.15, 1.71) <0.001 
Boss 1.70 (1.17, 2.48) 0.006 
Parents/In-laws 1.46 (1.23, 1.73) <0.001 
Coworkers 1.33 (1.04, 1.71) 0.023 
Friends 1.24 (1.07, 1.44) 0.005 
Therapist 0.91 (0.68, 1.23) 0.56 
Other 1.15 (0.85, 1.54) 0.37 
No one 0.77 (0.62, 0.95) 0.013 
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Table 2 (continued) 
Sources from which participants seek information 
WebMD/MayoClinic/Wikipedia/other online sources 1.08 (0.93, 1.25) 0.31 
Google/other search engines 0.94 (0.81, 1.08) 0.38 
Facebook/Twitter/other social networks 0.50 (0.36, 0.69) <0.001 
TV 0.64 (0.50, 0.82) <0.001 
Pharmaceutical/Healthcare company 0.64 (0.50, 0.83) <0.001 
Specific product web site 0.60 (0.46, 0.79) <0.001 
Articles in newspapers/magazines 1.09 (0.89, 1.33) 0.42 
Friends 0.88 (0.74, 1.05) 0.16 
Family 0.90 (0.77, 1.06) 0.21 
Your doctor 1.04 (0.88, 1.24) 0.64 
Advocacy group 1.62 (0.96, 2.74) 0.07 
Medical specialty society 1.19 (0.79, 1.80) 0.4 
Other 1.03 (0.70, 1.52) 0.88 
*Effect measures are ratio of means for number of healthcare professionals among patients who
have ever seen or spoken to at least one healthcare professionals and odds ratios for all other 
outcomes. Associations between variables of interest and IBS subtypes examined using 
multivariate logistic regression, negative binomial regression, and the proportional odds model 
where appropriate adjusting for age, sex, race/ethnicity, marital status, education level, 
employment status, and IBS diagnosed by a doctor.  
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